NCT00303940View on ClinicalTrials.gov

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

February 28, 2010

Conditions

Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney CancerLiver CancerNeuroblastomaOvarian CancerSarcomaUnspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG

carboplatin

DRUG

talabostat mesylate

DRUG

temozolomide

OTHER

pharmacological study

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00303940 - Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | Biotech Hunter | Biotech Hunter